Market Risers: Ashtead Group plc, AstraZeneca plc, Aviva plc, BAE Systems plc

BAE Systems plc
[shareaholic app="share_buttons" id_name="post_below_content"]

The stock price for Ashtead Group plc found using EPIC: LON:AHT has climbed 2.38% or 45.5 points throughout today’s trading session so far. Market buyers seem confident throughout the session. The high for the period has reached 1961 and hitting a low of 1943. Volume total for shares traded at this point reached 424,304 whilst the daily average number of shares exchanged is just 2,443,396. A 52 week high for the stock is 2185 amounting to 274 points in difference on the previous days close and a 52 week low being 1476 a difference of some 435 points. Ashtead Group plc has a 20 day moving average of 1976.61 and now the 50 day moving average now at 2033.26. The market cap now stands at £9,722.90m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for Ashtead Group plc being recorded at Thursday, April 5, 2018 at 12:34:35 PM GMT with the stock price trading at 1956.5 GBX.

 

 

Stock in AstraZeneca plc with ticker code: LON:AZN has moved up 1.05% or 51 points throughout the session so far. Traders have stayed positive during the trading session. The high for the period has reached 4945 dipping to 4900.5. Volume total for shares traded at this point reached 386,327 with the daily average traded share volume around 2,404,222. A 52 week share price high is 5520 around 653 points in difference on the previous days close and a 52 week low being 4260 which is a variance of 607 points. AstraZeneca plc now has a 20 moving average of 4874.14 and the 50 day SMA of 4877.14. This puts the market cap at £62,931.77m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Thursday, April 5, 2018 at 12:34:55 PM GMT with the stock price trading at 4918 GBX.

 

 

The trading price for Aviva plc found using EPIC: LON:AV has increased 1.15% or 5.56 points during the course of today’s session so far. Buyers are a positive bunch throughout the session. Range high for the period so far is 509.3 meanwhile the session low reached 487. The volume total for shares traded up to this point was 4,040,722 while the average shares exchanged is 11,994,530. The 52 week high price for the shares is 550 which comes in at 66.6 points difference from the previous days close and the 52 week low at 482.2 which is a difference of 1.19 points. Aviva plc now has a 20 SMA at 512.07 and now the 50 day MA at 508.91. This puts the market capitalisation now at £19,451.31m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Aviva plc being recorded at Thursday, April 5, 2018 at 12:34:45 PM GMT with the stock price trading at 488.96 GBX.

 

 

Shares in BAE Systems plc found using EPIC: LON:BA has climbed 2.46% or 14.2 points thoughout the session so far. Investors have so far held a positive outlook while the stock has been in play. Range high for the period so far is 593.6 dipping to 585. The volume total for shares traded up to this point was 2,420,152 with the average number of shares traded daily being 9,190,176. The 52 week high is 682.5 equating to 105.5 points difference from the previous close and the 52 week low at 533.5 is a variance of 43.5 points. BAE Systems plc now has a 20 simple moving average of 585.69 and the 50 day moving average now of 586.03. This puts the market capitalisation now at £18,748.97m at the time of this report. The share price is in GBX. Mcap is measured in GBP. This article was written with the last trade for BAE Systems plc being recorded at Thursday, April 5, 2018 at 12:34:54 PM GMT with the stock price trading at 591.2 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    Aviva plc announces a strategic acquisition of Direct Line, enhancing its growth and performance. The deal offers benefits for both customers and shareholders.
    AstraZeneca's Tagrisso gains EU approval for treating advanced NSCLC, showing significant efficacy in reducing disease progression in key trials.
    Ashtead Group plc announces a $1.5bn share buyback arrangement with Barclays Bank, aiming to reduce share capital within 18 months.

      Search

      Search